ArticleFrontiers in immunology2024

Ginsenoside Rg3 targets glycosylation of PD-L1 to enhance anti-tumor immunity in non-small cell lung cancer.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.